4/A
Changes in Ownership
Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-004954
Chief Executive Officer bought 1,340 shares at $7.64 ($10,238)
From the SEC's structured data for this filing
Trades in this filing
Cohen Yuval · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-11-22 | Purchase : show line 1 in the form | +1,340 | $7.64 | $10,238 | 32,830 | D |
| Open-market purchases · 1,340 sh · avg $7.64 · $10,238 | ||||||
Loading xslF345X03/doc4a.xml…